| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.00099 | 1 |